Moai Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
MaraBio Systemsmarabiosystems.cominSep 2024
MARAbio develops a blood test for mothers that detects Maternal Autoantibody Related Autism (MARA) by identifying a cluster of antibodies, aiming to predict the likelihood of MARA in a child before clinical symptoms appear.
BiotechDigital HealthFemTechSalt Lake City, US
Michael Paul(Executive Officer, Director)in
BoardMichael Kaufman(Director)Vincent Forlenza(Director)Craig Nemiroff(Director)Gail Page(Director)
PartnerBrian Jacobs· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

